Clinical Trials Logo
  1. Home
  2. Disuse Atrophy
  3. NCT01192009

Leucine Supplementation and Skeletal Muscle Disuse

Disuse Atrophy Clinical Trial

Official title:
Leucine and Skeletal Muscle Disuse: Clinical Anti-Atrophic Effectiveness and Related Mechanisms

Clinical Trial Summary

Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01192009
Study type Interventional
Source University of Sao Paulo
Contact
Status Completed
Phase N/A
Start date April 2011
Completion date February 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT04422665 - Preventing Bed-rest Induced Muscle Loss in the Elderly N/A
Completed NCT01588808 - Immobilization and Protein Supplementation (IM-PRO) N/A
Completed NCT01513486 - Electrical Stimulation During Immobilization N/A
Completed NCT01096524 - Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty Phase 3
Completed NCT02109380 - Bed-rest, Muscle Mass and Insulin Sensitivity N/A
Recruiting NCT06205784 - Prehabilitative Exercise Prior to Immobilization N/A
Completed NCT03454347 - The Efficacy of Protein Supplementation on Attenuating Muscle Atrophy Following Disuse in the Collegiate Population N/A
Recruiting NCT06228742 - Molecular Mechanisms Underlying Anabolic Resistance to Protein Intake During Muscle Disuse N/A